Trial Site Detail

 

Drug:
MAAT
Trial:
Cognitive Impairment in GIST Patients on Tyrosine Kinase Inhibitor Therapy: Cognitive Behavioral Therapy to Improve Cognitive Symptoms (GIST-MAAT)
Conditions: Gastrointestinal Stromal Tumor
Trial Status:
Terminated

 

University of Pittsburgh Cancer Institute

     
Pittsburgh , PA 15232
USA

 

Principal Investigator:
 Robert Ferguson, PhD
Contact:
 Alicia Brindle, BS 412-647-4817 alb330@pitt.edu
Activation Status of this Site:
 Active
Notes about this Site:
University of Pittsburgh Cancer Institute Website:

 

 

Navigating the Map

Use the plus (+) and minus (-) controls to zoom in/out.

Click and drag the map or use the arrows to move (pan) the map.

Tip: Click the marker before zooming and the map will stay centered on the marker as you zoom.